Investigative Report: $50 Billion in Questionable Medicare Payments
A detailed investigation uncovers $50 billion in Medicare payments for unverified diagnoses made by insurers, raising concerns about Medicare Advantage practices.
A detailed investigation uncovers $50 billion in Medicare payments for unverified diagnoses made by insurers, raising concerns about Medicare Advantage practices.
Chiquita Brooks-LaSure highlights critical issues from cuts in HHS that threaten nursing home oversight, impacting care quality and enforcement.
Explore how the Inflation Reduction Act impacts Medicare beneficiaries' access and costs for prescription medications, including significant changes in formulary access and cost-sharing for 2025.
An overview of Medicare fraud and its impact on government expenditures, highlighting necessary reforms to curb improper payments.
Congress has extended Medicare telehealth flexibilities to September 2025, addressing provider concerns over expiration.
The DOJ settles a significant Medicare Advantage fraud case, showcasing the commitment to fight healthcare fraud and ensure compliance with billing practices.
NEOS Investment Management increases stake in Centene Corporation amid mixed analyst ratings. Discover recent investment trends and Centene's financial performance.
Koreatown healthcare providers settle $62M for false Medicare claims.
An overview of the upcoming Medicare 2026 proposed payment regulations by CMS and their potential impact on healthcare policies and payment systems.
Aetna pauses proposed CPAP reimbursement changes amid concerns from AAHomecare about patient care disruptions.